{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:02:27Z","timestamp":1779670947686,"version":"3.53.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02132-4","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:35:55Z","timestamp":1775118955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research progress on the mechanisms of EB virus reshaping the immune microenvironment in nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Liu","family":"Yudie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Weihua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xinping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2132_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.4448","volume":"235","author":"SW Tsao","year":"2015","unstructured":"Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus inepithelial malignancies. J Pathol. 2015;235:323\u201333.","journal-title":"J Pathol"},{"key":"2132_CR2","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","volume":"15","author":"ET Chang","year":"2006","unstructured":"Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev. 2006;15:1765\u201377.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2132_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canlet.2020.02.010","volume":"477","author":"J Zhao","year":"2020","unstructured":"Zhao J, Guo C, Xiong F, Yu J, Ge J, Wang H, et al. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma. Cancer Lett. 2020;477:131\u201343.","journal-title":"Cancer Lett"},{"key":"2132_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789\u2013802.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2132_CR5","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.1038\/s41467-025-64037-2","volume":"16","author":"ZL Hu","year":"2025","unstructured":"Hu ZL, Li ZQ, Wang Y, et al. Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion. Nat Commun. 2025;16(1):9015.","journal-title":"Nat Commun"},{"issue":"1","key":"2132_CR6","doi-asserted-by":"publisher","first-page":"e1011934","DOI":"10.1371\/journal.ppat.1011934","volume":"20","author":"X Xu","year":"2024","unstructured":"Xu X, Zhu N, Zheng J, Peng Y, Zeng MS, Deng K, et al. EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation. PLoS Pathog. 2024;20(1):e1011934.","journal-title":"PLoS Pathog"},{"key":"2132_CR7","doi-asserted-by":"crossref","unstructured":"Purwono PB, Romdhoni AC, Rahaju AS et al. Expression Level of Latent Membrane Protein 1 Epstein-Barr Virus in Tissue Biopsy Among Different Clinical Stages of Nasopharyngeal Carcinoma, 20 October 2024, PREPRINT (Version 1) available at Research Square.doi:10.21203\/rs.3.rs-4955723\/v1.","DOI":"10.21203\/rs.3.rs-4955723\/v1"},{"key":"2132_CR8","unstructured":"Xiao B, Jizheng W, Yingxiang W, Xianfeng Z. Xiao Juan. Expression and clinical significance of LMP1 and CRT in NPC tissues [J]. Central South Medical Science Journal, 2025, (4): 613\u2013616."},{"key":"2132_CR9","unstructured":"Expression. and clinical significance of Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma, Wang Juan, 2009, Nanjing Medical University&#12290."},{"issue":"9","key":"2132_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.oraloncology.2007.11.005","volume":"44","author":"SH Chang","year":"2008","unstructured":"Chang SH, Chang HC, Hung WC. Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells. Oral Oncol. 2008;44(9):891\u20137.","journal-title":"Oral Oncol"},{"issue":"1","key":"2132_CR11","first-page":"13","volume":"49","author":"ZHANG Cui","year":"2024","unstructured":"Cui ZHANG, Yingling WU, Jingju DING, et al. Role of miR-34c downregulated by EBV in promoting proliferation and migration of nasopharyngeal carcinoma cells and its mechanism[J]. J Bengbu Med Univ. 2024;49(1):13\u20137.","journal-title":"J Bengbu Med Univ"},{"issue":"11","key":"2132_CR12","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","volume":"30","author":"S Jin","year":"2020","unstructured":"Jin S, Li R, Chen MY, et al. Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res. 2020;30(11):950\u201365.","journal-title":"Cell Res"},{"issue":"1","key":"2132_CR13","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41467-023-37614-6","volume":"14","author":"L Gong","year":"2023","unstructured":"Gong L, Luo J, Zhang Y, Yang Y, Li S, Fang X, et al. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. Nat Commun. 2023;14(1):1912.","journal-title":"Nat Commun"},{"key":"2132_CR14","doi-asserted-by":"publisher","first-page":"106999","DOI":"10.1016\/j.oraloncology.2024.106999","volume":"158","author":"Y Ge","year":"2024","unstructured":"Ge Y, Liu H, Huang W, et al. Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment. Oral Oncol. 2024;158:106999.","journal-title":"Oral Oncol"},{"issue":"7","key":"2132_CR15","doi-asserted-by":"publisher","first-page":"102200","DOI":"10.1016\/j.xcrm.2025.102200","volume":"6","author":"SX Liu","year":"2025","unstructured":"Liu SX, Wu TW, Luo DH, Zhang LL, Zhou L, et al. Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma. Cell Rep Med. 2025;6(7):102200.","journal-title":"Cell Rep Med"},{"key":"2132_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff YR, Warner AB, Wolchok JD. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res. 2020;30:507\u201319.","journal-title":"Cell Res"},{"key":"2132_CR17","doi-asserted-by":"publisher","first-page":"106242","DOI":"10.1016\/j.oraloncology.2022.106242","volume":"136","author":"Efficacy of Anti-PD1","year":"2023","unstructured":"Efficacy of Anti-PD1. Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis. Oral Oncol. 2023;136:106242.","journal-title":"Oral Oncol"},{"issue":"7","key":"2132_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1200\/JCO.20.02712","volume":"39","author":"FH Wang","year":"2021","unstructured":"Wang FH, Wei XL, Feng J, Li Q, Xu N, Hu XC, et al. Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02). J Clin Oncol. 2021;39(7):704\u201312.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2132_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-025-02273-0","volume":"10","author":"GJ Nuovo","year":"2025","unstructured":"Nuovo GJ, Tili E, Croce CM. Nasopharyngeal carcinoma: a model cancer to understand tumor rejection. Signal Transduct Target Ther. 2025;10(1):187.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2132_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12967-023-04112-8","volume":"21","author":"C Chen","year":"2023","unstructured":"Chen C, Wang C, Pang R, et al. Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma. J Transl Med. 2023;21(1):278.","journal-title":"J Transl Med"},{"key":"2132_CR21","doi-asserted-by":"publisher","first-page":"1124066","DOI":"10.3389\/fimmu.2023.1124066","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Lv S, Liu G, Lu N, Jiang Y, Liang H, et al. Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma. Front Immunol. 2023;14:1124066.","journal-title":"Front Immunol"},{"key":"2132_CR22","doi-asserted-by":"publisher","first-page":"592569","DOI":"10.3389\/fimmu.2020.592569","volume":"11","author":"J Busselaar","year":"2020","unstructured":"Busselaar J, Tian S, van Eenennaam H, Borst J. Helpless Priming Sends CD8\u2009+\u2009T Cells on the Road to Exhaustion. Front Immunol. 2020;11:592569.","journal-title":"Front Immunol"},{"issue":"8","key":"2132_CR23","doi-asserted-by":"publisher","first-page":"e1817","DOI":"10.1002\/ctm2.1817","volume":"14","author":"L Ni","year":"2024","unstructured":"Ni L. Potential mechanisms of cancer stem-like progenitor T-cell bio-behaviours. Clin Transl Med. 2024;14(8):e1817.","journal-title":"Clin Transl Med"},{"issue":"3","key":"2132_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/microorganisms9030603","volume":"9","author":"K Kase","year":"2021","unstructured":"Kase K, Kondo S, Wakisaka N, et al. Epstein-Barr virus LMP1 induces soluble PD-L1 in nasopharyngeal carcinoma. Microorganisms. 2021;9(3):603.","journal-title":"Microorganisms"},{"issue":"12","key":"2132_CR25","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/cac2.12619","volume":"44","author":"F He","year":"2024","unstructured":"He F, Gong Y, Tao G, Zhang J, Wu Q, Tan Y, et al. Targeting the LMP1-ALIX axis in EBV nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity. Cancer Commun (Lond). 2024;44(12):1391\u2013413.","journal-title":"Cancer Commun (Lond)"},{"issue":"6","key":"2132_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1158\/2326-6066.CIR-22-0374","volume":"11","author":"H Chen","year":"2023","unstructured":"Chen H, Duan X, Deng X, Huang Y, Zhou X, Zhang S, et al. EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression. Cancer Immunol Res. 2023;11(6):830\u201346.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2132_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X, et al. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nat Commun. 2022;13(1):866.","journal-title":"Nat Commun"},{"issue":"19","key":"2132_CR28","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-20-4321","volume":"81","author":"J Ge","year":"2021","unstructured":"Ge J, Wang J, Xiong F, Jiang X, Zhu K, Wang Y, et al. Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1. Cancer Res. 2021;81(19):5074\u201388.","journal-title":"Cancer Res"},{"issue":"6","key":"2132_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-21-2292","volume":"82","author":"X Duan","year":"2022","unstructured":"Duan X, Chen H, Zhou X, Liu P, Zhang X, Zhu Q, et al. EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation. Cancer Res. 2022;82(6):1070\u201383.","journal-title":"Cancer Res"},{"key":"2132_CR30","doi-asserted-by":"publisher","first-page":"857137","DOI":"10.3389\/fcell.2022.857137","volume":"10","author":"X Shi","year":"2022","unstructured":"Shi X, Pan J, Qiu F, et al. Multiscale Transcriptomic Integration Reveals B-Cell Depletion and T-Cell Mistrafficking in Nasopharyngeal Carcinoma Progression. Front Cell Dev Biol. 2022;10:857137.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"2132_CR31","doi-asserted-by":"publisher","first-page":"e2408788","DOI":"10.1002\/advs.202408788","volume":"12","author":"X Yu","year":"2025","unstructured":"Yu X, Qian J, Ding L, Pan C, Liu X, Wu Q, et al. Galectin-1-Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs. Adv Sci (Weinh). 2025;12(11):e2408788.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2132_CR32","doi-asserted-by":"publisher","first-page":"e1010200","DOI":"10.1371\/journal.ppat.1010200","volume":"18","author":"A Jorapur","year":"2022","unstructured":"Jorapur A, Marshall LA, Jacobson S, et al. EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22. PLoS Pathog. 2022;18(1):e1010200.","journal-title":"PLoS Pathog"},{"issue":"2","key":"2132_CR33","doi-asserted-by":"publisher","first-page":"e001588","DOI":"10.1136\/jitc-2020-001588","volume":"8","author":"S Huo","year":"2020","unstructured":"Huo S, Luo Y, Deng R, Liu X, Wang J, Wang L, et al. EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells. J Immunother Cancer. 2020;8(2):e001588.","journal-title":"J Immunother Cancer"},{"key":"2132_CR34","doi-asserted-by":"publisher","first-page":"815437","DOI":"10.3389\/fonc.2022.815437","volume":"12","author":"XM Ma","year":"2022","unstructured":"Ma XM, Luo YF, Zeng FF, et al. TGF-\u03b21-Mediated PD-L1 Glycosylation Contributes to Immune Escape via c-Jun\/STT3A Pathway in Nasopharyngeal Carcinoma. Front Oncol. 2022;12:815437.","journal-title":"Front Oncol"},{"issue":"28","key":"2132_CR35","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41388-024-03061-w","volume":"43","author":"Y Chen","year":"2024","unstructured":"Chen Y, Di M, Tang Y, Zhao J, Wang Q, Guo Z, et al. Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1\u03b1-VEGF pathway. Oncogene. 2024;43(28):2143\u201359.","journal-title":"Oncogene"},{"key":"2132_CR36","unstructured":"Bao Weijing N, Jiayu W, Rifu et al. EB virus induces M2-type tumor-associated macrophage polarization through inhibiting TP73, promoting the occurrence and development of NPC [J]. Chin J Otolaryngol Head Neck Surg, 2025, 32(12):630-635."},{"issue":"3","key":"2132_CR37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792\u2013e80923.","journal-title":"Cell"},{"key":"2132_CR38","doi-asserted-by":"publisher","first-page":"113944","DOI":"10.1016\/j.intimp.2024.113944","volume":"147","author":"Z Huang","year":"2025","unstructured":"Huang Z, Li Y, Liu Q, Chen X, Lin W, Wu W, et al. SPP1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma. Int Immunopharmacol. 2025;147:113944.","journal-title":"Int Immunopharmacol"},{"key":"2132_CR39","doi-asserted-by":"crossref","unstructured":"Sung WW, Chen PR, Liao MH, Lee JW. Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1. Exp Cell Res. 2017;359(1):94\u2013100. doi: 10.1016\/j.yexcr.2017.08.005. PMID: 28782518.","DOI":"10.1016\/j.yexcr.2017.08.005"},{"issue":"12","key":"2132_CR40","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu YR, Imrichova H, Wang H, et al. Disturbed mitochondrial dynamics in CD8\u2009+\u2009TILs reinforce T cell exhaustion. Nat Immunol. 2020;21(12):1540\u201351.","journal-title":"Nat Immunol"},{"key":"2132_CR41","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3389\/fimmu.2020.01906","volume":"11","author":"YN Liu","year":"2020","unstructured":"Liu YN, Yang JF, Huang DJ, et al. Hypoxia induces mitochondrialdefect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways. Front Immunol. 2020;11:1906.","journal-title":"Front Immunol"},{"issue":"6","key":"2132_CR42","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/cancers12061616","volume":"12","author":"SH Lee","year":"2020","unstructured":"Lee SH, Griffiths JR. How and why are cancers acidic? Carbonicanhydrase IX and the homeostatic control of tumour extracellular pH. Cancer. 2020;12(6):1616. https:\/\/doi.org\/10.3390\/cancers12061616.","journal-title":"Cancer"},{"issue":"11","key":"2132_CR43","doi-asserted-by":"publisher","first-page":"108500","DOI":"10.1016\/j.celrep.2020.108500","volume":"33","author":"WJ Quinn","year":"2020","unstructured":"Quinn WJ, Jiao J, TeSlaa T, et al. Lactate limits T cell proliferation viathe NAD(H) redox state. Cell Rep. 2020;33(11):108500.","journal-title":"Cell Rep"},{"issue":"2","key":"2132_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201\u2013e2189.","journal-title":"Cancer Cell"},{"issue":"13","key":"2132_CR45","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.7150\/thno.100171","volume":"14","author":"T Xiang","year":"2024","unstructured":"Xiang T, Sun F, Liu T, Zhao J, Yang J, Ouyang D, et al. EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment. Theranostics. 2024;14(13):5123\u201340.","journal-title":"Theranostics"},{"issue":"1","key":"2132_CR46","doi-asserted-by":"publisher","first-page":"9394","DOI":"10.1038\/s41467-024-53593-8","volume":"15","author":"H Shen","year":"2024","unstructured":"Shen H, Ojo OA, Ding H, et al. HIF1\u03b1-regulated glycolysis promotes activation-induced cell death and IFN-\u03b3 induction in hypoxic T cells. Nat Commun. 2024;15(1):9394.","journal-title":"Nat Commun"},{"issue":"6","key":"2132_CR47","doi-asserted-by":"publisher","first-page":"e02168","DOI":"10.1128\/JVI.02168-16","volume":"91","author":"J Zhang","year":"2017","unstructured":"Zhang J, Jia L, Lin W, Yip YL, Lo KW, Lau VMY, et al. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1\/NF-\u03baB Signaling Pathways. J Virol. 2017;91(6):e02168\u201316.","journal-title":"J Virol"},{"issue":"11","key":"2132_CR48","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/v16111660","volume":"16","author":"J Yu","year":"2024","unstructured":"Yu J, Wang Y, Wang H, Wei Z, Pei Y. Decoding Critical Targets and Signaling Pathways in EBV-Mediated Diseases Using Large Language Models. Viruses. 2024;16(11):1660.","journal-title":"Viruses"},{"issue":"4","key":"2132_CR49","doi-asserted-by":"publisher","first-page":"e1008532","DOI":"10.1371\/journal.ppat.1008532","volume":"16","author":"X Lyu","year":"2020","unstructured":"Lyu X, Wang J, Guo X, Wu G, Jiao Y, Faleti OD, et al. Correction: EBV-miR-BART1-5P activates AMPK\/mTOR\/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma. PLoS Pathog. 2020;16(4):e1008532.","journal-title":"PLoS Pathog"},{"issue":"5","key":"2132_CR50","doi-asserted-by":"publisher","first-page":"999","DOI":"10.32604\/or.2024.046679","volume":"32","author":"X Zhao","year":"2024","unstructured":"Zhao X, Huang X, Dang C, Wang X, Qi Y, Li H. The Epstein-Barr virus-miRNA-BART6-5p regulates TGF-\u03b2\/SMAD4 pathway to induce glycolysis and enhance proliferation and metastasis of gastric cancer cells. Oncol Res. 2024;32(5):999\u20131009.","journal-title":"Oncol Res"},{"issue":"6","key":"2132_CR51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307\u201325.","journal-title":"Nat Rev Cancer"},{"key":"2132_CR52","doi-asserted-by":"publisher","first-page":"107129","DOI":"10.1016\/j.oraloncology.2024.107129","volume":"160","author":"H Li","year":"2025","unstructured":"Li H, Lou L, Du J, Li M, Wen X, et al. Multimodal profiling uncovers tertiary lymphoid structures as a critical determinant of immunotherapy response and prognosis in nasopharyngeal carcinoma. Oral Oncol. 2025;160:107129.","journal-title":"Oral Oncol"},{"key":"2132_CR53","doi-asserted-by":"crossref","unstructured":"Lin H, Wu Y, Tang F, et al. Deciphering the metabolic-epigenetic-immune crosstalk in Epstein-Barr virus-positive nasopharyngeal carcinoma: mechanisms and novel therapeutic frontiers. Int Immunopharmacol. 2025 Oct 30;164:115404.","DOI":"10.1016\/j.intimp.2025.115404"},{"issue":"6","key":"2132_CR54","doi-asserted-by":"publisher","first-page":"e0224321","DOI":"10.1128\/mBio.02243-21","volume":"12","author":"D Westhoff Smith","year":"2021","unstructured":"Westhoff Smith D, Chakravorty A, Hayes M, et al. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells. mBio. 2021;12(6):e0224321.","journal-title":"mBio"},{"issue":"36","key":"2132_CR55","doi-asserted-by":"publisher","first-page":"e2403161","DOI":"10.1002\/advs.202403161","volume":"11","author":"X Wan","year":"2024","unstructured":"Wan X, Liu Y, Peng Y, et al. Primary and Orthotopic Murine Models of Nasopharyngeal Carcinoma Reveal Molecular Mechanisms Underlying its Malignant Progression. Adv Sci (Weinh). 2024;11(36):e2403161.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"2132_CR56","doi-asserted-by":"publisher","first-page":"e1486950","DOI":"10.1080\/2162402X.2018.1486950","volume":"7","author":"P Gravelle","year":"2018","unstructured":"Gravelle P, P\u00e9ricart S, Tosolini M, Fabiani B, Coppo P, Amara N, et al. EBV infection determines the immune hallmarks of plasmablastic lymphoma. Oncoimmunology. 2018;7(10):e1486950.","journal-title":"Oncoimmunology"},{"issue":"9","key":"2132_CR57","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/hed.25195","volume":"40","author":"ML Ooft","year":"2018","unstructured":"Ooft ML, van Ipenburg J, van de Loo RJM, et al. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma. Head Neck. 2018;40(9):1986\u201398.","journal-title":"Head Neck"},{"issue":"22","key":"2132_CR58","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1200\/JCO.22.00327","volume":"40","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, et al. Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial. J Clin Oncol. 2022;40(22):2420\u20135.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2132_CR59","doi-asserted-by":"publisher","first-page":"EVIDoa2400214","DOI":"10.1056\/EVIDoa2400214","volume":"4","author":"PY Huang","year":"2025","unstructured":"Huang PY, Chen XY, Ding X, et al. Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma. NEJM Evid. 2025;4(5):EVIDoa2400214.","journal-title":"NEJM Evid"},{"key":"2132_CR60","doi-asserted-by":"publisher","first-page":"103615","DOI":"10.1016\/j.eclinm.2025.103615","volume":"90","author":"YC Li","year":"2025","unstructured":"Li YC, Li XY, Lan KQ, et al. Epstein-Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trial. EClinicalMedicine. 2025;90:103615.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"2132_CR61","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S1470-2045(24)00504-7","volume":"25","author":"SL Liu","year":"2024","unstructured":"Liu SL, Li XY, Yang JH, et al. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2024;25(12):1563\u201375.","journal-title":"Lancet Oncol"},{"issue":"11","key":"2132_CR62","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jama.2025.13205","volume":"334","author":"C Xu","year":"2025","unstructured":"DIAMOND Study Group, Xu C, Liang XY, Huang XQ. Jet al. Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial. JAMA. 2025;334(11):973\u201383.","journal-title":"JAMA"},{"key":"2132_CR63","doi-asserted-by":"crossref","unstructured":"Huang Y, Sun D, Zhou H, et al. Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial. JAMA Oncol. 2026 Jan 29:e256245.doi: 10.1001\/jamaoncol.2025.6245.","DOI":"10.1001\/jamaoncol.2025.6245"},{"key":"2132_CR64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.oraloncology.2019.04.024","volume":"93","author":"X Guo","year":"2019","unstructured":"Guo X, Li T, Li F, et al. Intermittent abortive reactivation of Epstein-Barr virus during the progression of nasopharyngeal cancer as indicated by elevated antibody levels. Oral Oncol. 2019;93:85\u201390.","journal-title":"Oral Oncol"},{"issue":"1","key":"2132_CR65","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1186\/s12903-025-06733-5","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y, Wu L, Huang Z, et al. Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas. BMC Oral Health. 2025;25(1):1361.","journal-title":"BMC Oral Health"},{"issue":"8","key":"2132_CR66","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.3390\/jcm12083005","volume":"12","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Yuan M, Liu Z, et al. Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein-Barr Virus Status in the Chinese Population: A Multicenter Investigation. J Clin Med. 2023;12(8):3005.","journal-title":"J Clin Med"},{"issue":"1","key":"2132_CR67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13027-025-00661-3","volume":"20","author":"GZ Lu","year":"2025","unstructured":"Lu GZ, Huang YX, Guo LF, et al. Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma. Infect Agent Cancer. 2025;20(1):30.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"2132_CR68","doi-asserted-by":"publisher","first-page":"2026583","DOI":"10.1080\/2162402X.2022.2026583","volume":"11","author":"WS Peng","year":"2022","unstructured":"Peng WS, Zhou X, Yan WB, et al. Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing. Oncoimmunology. 2022;11(1):2026583.","journal-title":"Oncoimmunology"},{"key":"2132_CR69","doi-asserted-by":"publisher","first-page":"714433","DOI":"10.3389\/fonc.2021.714433","volume":"11","author":"L Zhu","year":"2021","unstructured":"Zhu L, Ouyang T, Xiong Y, et al. Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma. Front Oncol. 2021;11:714433.","journal-title":"Front Oncol"},{"issue":"6","key":"2132_CR70","first-page":"463","volume":"47","author":"WR Luo","year":"2025","unstructured":"Luo WR. [Rethinking cancer]. Zhonghua Zhong Liu Za Zhi. 2025;47(6):463\u20137. Chinese.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2132_CR71","doi-asserted-by":"publisher","first-page":"1120290","DOI":"10.3389\/fbinf.2023.1120290","volume":"3","author":"X Li","year":"2023","unstructured":"Li X, Gibson G, Qiu P. Gene representation in scRNA-seq is correlated with common motifs at the 3\u2019 end of transcripts. Front Bioinform. 2023;3:1120290.","journal-title":"Front Bioinform"},{"issue":"1","key":"2132_CR72","doi-asserted-by":"publisher","first-page":"e70018","DOI":"10.1111\/sms.70018","volume":"35","author":"L Veschetti","year":"2025","unstructured":"Veschetti L, Patuzzo C, Treccani M, Moron Dalla Tor L, Deiana M, Cheri S, et al. Single-Cell RNA Sequencing Analysis Reveals Exercise-Induced Transcriptional Dynamics in Half-Marathon Runners. Scand J Med Sci Sports. 2025;35(1):e70018.","journal-title":"Scand J Med Sci Sports"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02132-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:03:10Z","timestamp":1779667390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02132-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2132"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02132-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}